apollo
0
Written By Bayyarapu Mahesh Kumar , M Pharmacy
Reviewed By Dr Aneela Siddabathuni , MPharma., PhD
Last Updated Sep 30, 2024 | 4:52 PM IST

Synstim 50 mg Combipack Injection 1's is used to treat Multiple myeloma, advanced cancer of the ovaries, childhood neuroblastoma (cancer of the nervous system), malignant melanoma (skin cancer) and soft tissue sarcoma. It contains Melphalan, which reduces the number of abnormal cells your body makes. Thus, it treats cancer efficiently. The most common adverse reactions observed in patients treated with this medicine are neutrophil count decreased, white blood cell count decreased, platelet count decreased, lymphocyte count decreased, diarrhoea, fatigue, anaemia, nausea, vomiting and hypokalemia.

Read more
Prescription drug

Whats That

tooltip
Prescription drug
 Trailing icon
Consult Doctor

Composition

MELPHALAN-50MG

Manufacturer/Marketer

Zydus Cadila

Consume Type

PARENTERAL

Return Policy

Not Returnable

Expires on or after

Jan-26

for this medicine

About Synstim 50 mg Combipack Injection 1's

Synstim 50 mg Combipack Injection 1's belongs to a class of alkylating agents, also known as chemotherapeutic agents. It is used to treat various cancer conditions such as multiple myeloma ((a type of cancer that develops from cells in the bone marrow called plasma cells), advanced cancer of the ovaries, childhood neuroblastoma (cancer of the nervous system), malignant melanoma (skin cancer) and soft tissue sarcoma. Cancer is a genetic change in which the body's cells divide uncontrollably and spread into surrounding tissues. Synstim 50 mg Combipack Injection 1's is also used to destroy bone marrow and cancer cells in preparation for a bone marrow transplant in people with multiple myeloma.

Synstim 50 mg Combipack Injection 1's contains Melphalan, which reduces the number of abnormal cells your body makes. Thus, it treats cancer efficiently.

Synstim 50 mg Combipack Injection 1's will be administered only in a hospital setting by an experienced healthcare professional. The most common adverse reactions observed in patients treated with Synstim 50 mg Combipack Injection 1's are neutrophil count decreased, white blood cell count decreased, platelet count decreased, lymphocyte count decreased, diarrhoea, fatigue, anaemia, nausea, vomiting and hypokalemia. Most of these side effects do not require medical attention and will resolve gradually. However, you are advised to talk to your doctor if any of these side effects persist or worsen.

Treatment with Synstim 50 mg Combipack Injection 1's is not advised during pregnancy since it may harm the fetus. If you are already pregnant, you should inform your doctor before receiving Synstim 50 mg Combipack Injection 1's. To avoid pregnancy while on treatment with Synstim 50 mg Combipack Injection 1's, you or your partner must use reliable contraceptive precautions. Inform you are doctor if you are breastfeeding.

Uses of Synstim 50 mg Combipack Injection 1's

Treatment of Multiple myeloma, advanced cancer of the ovaries, childhood neuroblastoma (cancer of the nervous system), malignant melanoma (skin cancer) and soft tissue sarcoma

Medicinal Benefits

Synstim 50 mg Combipack Injection 1's is an alkylating medicine, also known as a chemotherapeutic agent, primarily used to treat various cancer conditions such as multiple myeloma (a type of cancer that develops from cells in the bone marrow called plasma cells), advanced cancer of the ovaries, childhood neuroblastoma (cancer of the nervous system), malignant melanoma (skin cancer) and soft tissue sarcoma. Melphalan, present in Synstim 50 mg Combipack Injection 1's, works by reducing the number of abnormal cells produced by your body. As a result, it effectively treats cancer.

Directions for Use

Synstim 50 mg Combipack Injection 1's will be given to you by your healthcare professional.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Synstim 50 mg Combipack Injection 1's

  • A drop in the number of blood cells and platelets
  • Nausea
  • Vomiting
  • Diarrhoea
  • Mouth ulcers
  • Diarrhea
  • Fatigue
  • Anemia
  • Hypokalemia (low potassium)

Drug Warnings

Before taking Synstim 50 mg Combipack Injection 1's inform your doctor if you are pregnant or breastfeeding. If you become pregnant while on treatment with Synstim 50 mg Combipack Injection 1's, inform your doctor. Before taking Synstim 50 mg Combipack Injection 1's, inform your doctor about your medical history and ongoing therapies to rule out potential adverse effects or interactions. Always take Synstim 50 mg Combipack Injection 1's as prescribed by your doctor. It's crucial to take your medication as directed. The dosage of this medicine is based on your condition. Your doctor may adjust your dose during therapy based on the results of the treatment. If you have kidney issues, your doctor will usually give you a lower dose than other adults. Your doctor will determine if you should undergo preventive medication for blood clots in the veins. This applies during the first 5 months of treatment or if you have an elevated risk of developing a blood clot in your veins. The amount of blood cells in your bone marrow may drastically drop if you take Synstim 50 mg Combipack Injection 1's. In addition to raising your chance of getting a serious infection or bleeding, this could result in specific symptoms. Please contact your doctor right away if you encounter any of the following symptoms: abnormal bleeding or bruises; bloody or black, tarry stools; bloody vomit; or vomiting blood or brown material that resembles coffee grounds; fever, sore throat, persistent cough and congestion, or other symptoms of infection. Remember to keep all of your doctor's and the lab's appointments. Before and throughout your treatment, your doctor will order routine laboratory testing to determine whether this medication is having an impact on your blood cells. Synstim 50 mg Combipack Injection 1's may make you more susceptible to getting other cancers. Talk to your doctor to know more about Synstim 50 mg Combipack Injection 1's.

Drug Interactions

Drug-Drug Interactions: Synstim 50 mg Combipack Injection 1's may interact with cancer medications (e.g. adalimumab), vaccines (e.g. BCG vaccine, influenza virus vaccine), medications used to treat Multiple Sclerosis (e.g. cladribine), schizophrenia medications (e.g. clozapine), medicines used to treat moderate to severe plaque psoriasis (e.g. Deucravacitinib), medicines used to manage and treat autoimmune conditions (e.g. etanercept), antirheumatic drug (e.g. leflunomide).

Drug-Food Interactions: Avoid the consumption of alcoholic beverages.

Drug-Disease Interactions: Synstim 50 mg Combipack Injection 1's may interact with disease conditions, including infections, myelosuppression (bone marrow doesn't make enough blood cells or platelets), pulmonary pneumonitis (an irritating substance causes the tiny air sacs (alveoli) in your lungs to become inflamed)/fibrosis and renal dysfunction.

Drug-Drug Interactions Checker List

  • ADALIMUMAB
  • BCG VACCINE
  • INFLUENZA VIRUS VACCINE
  • CLADRIBINE
  • CLOZAPINE
  • DEUCRAVACITINIB
  • ETANERCEPT
  • LEFLUNOMIDE

Habit Forming

No

Diet & Lifestyle Advise

  • De-stress yourself by meditating, reading books, taking a warm bubble bath or listening to soothing music.
  • Performing yoga may also help in improving both physical and mental health.
  • Maintain a healthy weight by performing regular low-strain exercises and eating healthy food.
  • Eat a healthy diet and exercise regularly to maintain proper weight.
  • Include leafy vegetables, citrus fruits, fatty fish, berries, yoghurt, apples, peaches, cauliflower, cabbage, broccoli, beans, and herbs.
  • Get optimal sleep; rest well.
  • Avoid smoking and alcohol consumption.
  • Avoid fast food, fried food, processed meats, refined carbs and added sugars.

Special Advise

When you take Synstim 50 mg Combipack Injection 1's, your doctor will suggest regular blood tests to monitor the count of blood cells.

Disease/Condition Glossary

Cancer: Cancer is a genetic change in which the body's cells divide uncontrollably and spread into surrounding tissues. There are two types of cancer: benign (localized) and metastatic (spread to the whole body). Types of cancer include blood, lung, breast, etc. Cancer growth can be prevented by chemotherapy, radiation, and stem cell therapy.

Multiple myeloma: Multiple myeloma is a type of cancer affecting white blood cells called plasma cells. These cells collect in the bone marrow and divide uncontrollably, leading to kidney and bone damage. Symptoms include bone pain, loss of appetite, fever, and frequent infections. Generally, multiple myeloma cannot be cured, but the signs and symptoms can be reduced greatly or disappear after a period of time.

Ovarian cancer: Ovarian cancer begins in the ovaries (one of a pair of female reproductive glands in which the ova, or eggs, are formed).

Childhood neuroblastoma: Neuroblastoma is a rare type of cancer that occurs in nerve tissue. It usually affects children under the age of five. Fatigue, decreased appetite, and a lump in the chest, neck, or belly are all symptoms. Chemotherapy, surgery, and radiation therapy are all options for treatment.

Malignant Melanoma: Melanoma is a type of skin cancer in which the cancer cells grow in melanocytes. It is mainly caused by harmful UV radiation from the sun. When the cancer cells spread to other parts of the body, it is known as Metastasis. Malignant melanoma is common in fair-skinned and freckled individuals. It results in mole formation, typically on the skin of the face. 

Soft tissue sarcoma: Soft tissue sarcoma is an uncommon type of cancer that begins with cell proliferation in the body's soft tissues. Soft tissue sarcoma can develop in any part of the body. It most commonly occurs in the arms, legs, and belly.

bannner image

Alcohol

Caution

Avoid alcohol consumption while on treatment with Synstim 50 mg Combipack Injection 1's.

bannner image

Pregnancy

Caution

Synstim 50 mg Combipack Injection 1's should not be used during pregnancy. So, inform your doctor if you are pregnant or suspect pregnancy. You or your partner must use a reliable form of contraception to prevent pregnancy while taking these medications.

bannner image

Breast Feeding

Caution

If you are breastfeeding, inform your doctor. You should not breastfeed while on treatment with Synstim 50 mg Combipack Injection 1's.

bannner image

Driving

Caution

It is unknown whether Synstim 50 mg Combipack Injection 1's alters the ability to drive, so do not drive or operate machinery if you experience any symptoms affecting your ability to concentrate and react.

bannner image

Liver

Caution

If you have a pre-existing or a history of liver disease, inform your doctor before taking Synstim 50 mg Combipack Injection 1's.

bannner image

Kidney

Caution

If you have a pre-existing or a history of kidney disease, inform your doctor before taking Synstim 50 mg Combipack Injection 1's. Your doctor may titrate the dose if required based on your condition.

bannner image

Children

Caution

Synstim 50 mg Combipack Injection 1's is only not recommended for use in children as the safety and effectiveness have not been established.

Country of origin

India

Manufacturer/Marketer address

Zydus Tower, Satellite Cross Roads,Ahmedabad - 380015 Gujarat, India.
Other Info - SYN0415

Author Details

Doctor imageWe provide you with authentic, trustworthy and relevant information

FAQs

Synstim 50 mg Combipack Injection 1's is used to treat Multiple myeloma, advanced cancer of the ovaries, childhood neuroblastoma (cancer of the nervous system), malignant melanoma (skin cancer) and soft tissue sarcoma.
Synstim 50 mg Combipack Injection 1's contains Melphalan, which works by reducing the number of abnormal cells your body makes. Thus, it treats cancer efficiently.
While taking Synstim 50 mg Combipack Injection 1's, make sure to attend all of your doctor's appointments to ensure the therapy is effective. Blood tests and weight checks must be monitored on a regular basis. Both men and women should utilize an effective method of contraception while taking Synstim 50 mg Combipack Injection 1's.
Melphalan can cause a significant decrease in the number of blood cells and platelets. Your doctor may suggest laboratory tests before and during the treatment.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.

Add to Cart